V-Bio Ventures has 1 portfolio company on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Agomab Therapeutics's $74M Series B+ round in March 2021, alongside Redmile Group, Pontifax, OMNES Capital and 4 others. That company is in Health and bio. It has co-invested with OMNES Capital, Boehringer Ingelheim Venture Fund and Pontifax, most often OMNES Capital (2 rounds).

What V-Bio Ventures invests in

• Health and bio · 1 · 100%

How V-Bio Ventures invests

Share is of the 2 rounds on Recent Funding that name V-Bio Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

V-Bio Ventures portfolio companies

• AAgomab Therapeutics$74MSeries B+ · Mar 2021

Most frequent co-investors

• OOMNES Capital2 shared rounds · last Mar 10, 2021
• BBoehringer Ingelheim Venture Fund2 shared rounds · last Mar 10, 2021
• PPontifax2 shared rounds · last Mar 10, 2021
• AAdBio partners2 shared rounds · last Mar 10, 2021
• AAndera Partners1 shared round · last Mar 10, 2021
• CCormorant Asset Management1 shared round · last Mar 10, 2021
• RRedmile Group1 shared round · last Mar 10, 2021

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• FFirst Imagine!1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists V-Bio Ventures, which is a subset of its real portfolio. API: /api/v1/investors/v-bio-ventures (get a free API key). More: the most active VC firms and new venture capital funds.